120
Views
35
CrossRef citations to date
0
Altmetric
Original Research

Sensitization to Aspergillus fumigatus as a risk factor for bronchiectasis in COPD

, , , , , , , , & show all
Pages 2629-2638 | Published online: 31 Aug 2017

References

  • BarnesPJBurneyPGSilvermanEKChronic obstructive pulmonary diseaseNat Rev Dis Primers201511507627189863
  • VogelmeierCFCrinerGJMartinezFJGlobal strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summaryAm J Respir Crit Care Med2017195555758228128970
  • HanMKAgustiACalverleyPMChronic obstructive pulmonary disease phenotypes: the future of COPDAm J Respir Crit Care Med2010182559860420522794
  • BarkerBLBrightlingCEPhenotyping the heterogeneity of chronic obstructive pulmonary diseaseClin Sci2013124637138723190267
  • JamiesonDBMatsuiECBelliAEffects of allergic phenotype on respiratory symptoms and exacerbations in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2013188218719223668455
  • BafadhelMMckennaSAgbetileJAspergillus fumigatus during stable state and exacerbations of COPDEur Respir J2014431647123598955
  • JinJLiuXSunYThe prevalence of increased serum IgE and Aspergillus sensitization in patients with COPD and their association with symptoms and lung functionRespir Res201415113025359094
  • CrameriRThe problem of cross-reactivity in the diagnosis of fungal allergyClin Exp Allergy201141330230421294784
  • HemmannSMenzGIsmailCBlaserKCrameriRSkin test reactivity to 2 recombinant Aspergillus fumigatus allergens in A. fumigatus-sensitized asthmatic subjects allows diagnostic separation of allergic bronchopulmonary aspergillosis from fungal sensitizationJ Allergy Clin Immunol19991043 pt 160160710482834
  • KnutsenAPHutchesonPSSlavinRGKurupVPIgE antibody to Aspergillus fumigatus recombinant allergens in cystic fibrosis patients with allergic bronchopulmonary aspergillosisAllergy200459219820314763934
  • HurstJRElbornJSSoyzaADCOPD-bronchiectasis overlap syndromeEur Respir J201545231031325653262
  • PatelISVlahosIWilkinsonTMBronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2004170440040715130905
  • GatheralTKumarNSansomBCOPD-related bronchiectasis; independent impact on disease course and outcomesCOPD201411660561424983298
  • DuQJinJLiuXSunYBronchiectasis as a comorbidity of chronic obstructive pulmonary disease: a systematic review and meta-analysisPLoS One2016113e015053226978269
  • Martínez-GarcíaM-Ade la Rosa CarrilloDSoler-CataluñaJ-JPrognostic value of bronchiectasis in patients with moderate-to-severe chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2013187882383123392438
  • McDonnellMJAlibertiSGoeminnePCComorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort studyLancet Respir Med201641296997927864036
  • ColePJInflammation: a two-edged sword – the model of bronchiectasisEur J Respir Dis Suppl19861476153533593
  • De SoyzaAAlibertiSBronchiectasis and Aspergillus: how are they linked?Med Mycol2016551698127794529
  • KreindlerJLSteeleCNguyenNVitamin D3 attenuates Th2 responses to Aspergillus fumigatus mounted by CD4+ T cells from cystic fibrosis patients with allergic bronchopulmonary aspergillosisJ Clin Invest201012093242325420714107
  • CoughlanCAChotirmallSHRenwickJThe effect of Aspergillus fumigatus infection on vitamin D receptor expression in cystic fibrosisAm J Respir Crit Care Med201218610999100722904183
  • LiPXuXCaoEVitamin D deficiency causes defective resistance to Aspergillus fumigatus in mice via aggravated and sustained inflammationPLoS One201496e9980524926881
  • ChalmersJDMcHughBJDochertyCGovanJRHillATVitamin-D deficiency is associated with chronic bacterial colonisation and disease severity in bronchiectasisThorax2013681394723076388
  • JanssensWBouillonRClaesBVitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding geneThorax201065321522019996341
  • BestallJCPaulEAGarrodRGarnhamRJonesPWWedzichaJAUsefulness of the medical research council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary diseaseThorax199954758158610377201
  • van IerselCAde KoningHJDraismaGRisk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON)Int J Cancer2007120486887417131307
  • MillerMRHankinsonJBrusascoVATS/ERS Task ForceStandardisation of spirometryEur Respir J200526231933816055882
  • RosenbergEThe 1995 update of recommendations for a standard technique for measuring the single-breath carbon monoxide diffusing capacity (transfer factor)Am J Respir Crit Care Med19961543 pt 18278288845993
  • NaidichDPMcCauleyDIKhouriNFStitikFPSiegelmanSSComputed tomography of bronchiectasisJ Comput Assist Tomogr1982634374447096687
  • ChalmersJDGoeminnePAlibertiSThe bronchiectasis severity index. An international derivation and validation studyAm J Respir Crit Care Med2014189557658524328736
  • LynchDANewellJDTschomperBACinkTMNewmanLSBethelRUncomplicated asthma in adults: comparison of CT appearance of the lungs in asthmatic and healthy subjectsRadiology199318838298338351357
  • ZetterströmOJohanssonSGIgE concentrations measured by PRIST in serum of healthy adults and in patients with respiratory allergy. A diagnostic approachAllergy19813685375477337200
  • Global Initiative for Chronic Obstructive Lung Disease [homepage on the Internet]From the Global Strategy for the Diagnosis, Management and Prevention of COPDGlobal Initiative for Chronic Obstructive Lung Disease (GOLD)2017 Available from: http://goldcopd.orgAccessed July 6, 2017
  • AgarwalRHazarikaBGuptaDAggarwalANChakrabartiAJindalSKAspergillus hypersensitivity in patients with chronic obstructive pulmonary disease: COPD as a risk factor for ABPA?Med Mycol201048798899420370368
  • AgarwalRBhogalSChoudharyHAspergillus sensitisation in bidi smokers with and without chronic obstructive lung diseaseMycoses201760638138628139853
  • KespohlSMaryskaSBüngerJHow to diagnose mould allergy? Comparison of skin prick tests with specific IgE resultsClin Exp Allergy201646798199127027397
  • MariASchneiderPWallyVBreitenbachMSimon-NobbeBSensitization to fungi: epidemiology, comparative skin tests, and IgE reactivity of fungal extractsClin Exp Allergy200333101429143814519151
  • FattahiFten HackenNHLöfdahlCGAtopy is a risk factor for respiratory symptoms in COPD patients: results from the EUROSCOP studyRespir Res20131411023356508
  • MáizLVendrellMOlveiraCGirónRNietoRMartínez-GarcíaMÁPrevalence and factors associated with isolation of Aspergillus and Candida from sputum in patients with non-cystic fibrosis bronchiectasisRespiration201589539640325924628
  • WeigtSSCopelandCAFDerhovanessianAColonization with small conidia Aspergillus species is associated with bronchiolitis obliterans syndrome: a two-center validation study: Aspergillus conidia size and risk of BOSAm J Transplant201313491992723398785
  • WoolnoughKFRichardsonMNewbyCThe relationship between biomarkers of fungal allergy and lung damage in asthmaClin Exp Allergy2017471485627805757
  • JinJYuWLiSLuLLiuXSunYFactors associated with bronchiectasis in patients with moderate–severe chronic obstructive pulmonary diseaseMedicine (Baltimore)20169529e421927442646
  • OgumaTAsanoKTomomatsuKInduction of mucin and MUC5AC expression by the protease activity of Aspergillus fumigatus in airway epithelial cellsJ Immunol20111872999100521685325
  • NamvarSWarnPFarnellEAspergillus fumigatus proteases, Asp f 5 and Asp f 13, are essential for airway inflammation and remodelling in a murine inhalation modelClin Exp Allergy201545598299325270353
  • AgarwalRChakrabartiAShahAABPA complicating asthma ISHAM working groupAllergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteriaClin Exp Allergy201343885087323889240
  • AgarwalRDuaDChoudharyHRole of Aspergillus fumigatus-specific IgG in diagnosis and monitoring treatment response in allergic bronchopulmonary aspergillosisMycoses2017601333927523578
  • BarnesPJInflammatory mechanisms in patients with chronic obstructive pulmonary diseaseJ Allergy Clin Immunol20161381162727373322
  • BaxterCGDunnGJonesAMNovel immunologic classification of aspergillosis in adult cystic fibrosisJ Allergy Clin Immunol20131323560566.e1023726262
  • FukutomiYTaniguchiMSensitization to fungal allergens: resolved and unresolved issuesAllergol Int201564432133126433528
  • JolinkHde BoerRWillemsLNvan DisselJTFalkenburgJHHeemskerkMHT helper 2 response in allergic bronchopulmonary aspergillosis is not driven by specific Aspergillus antigensAllergy201570101336133926179335
  • AgustiACalverleyPMCelliBEvaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigatorsCharacterisation of COPD heterogeneity in the ECLIPSE cohortRespir Res201011112220831787
  • BafadhelMUmarIGuptaSThe role of CT scanning in multidimensional phenotyping of COPDChest2011140363464221454400
  • ReiffDBWellsAUCarrDHColePJHansellDMCT findings in bronchiectasis: limited value in distinguishing between idiopathic and specific typesAJR Am J Roentgenol199516522612677618537
  • PasteurMCHelliwellSMHoughtonSJAn investigation into causative factors in patients with bronchiectasisAm J Respir Crit Care Med20001624 pt 11277128411029331
  • QuintJKMillettERJoshiMChanges in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort studyEur Respir J201647118619326541539